Blockchain innovations for addressing pharmaceutical counterfeit in the global supply chain: a PLS–ANN approach.
Saved in:
| Title: | Blockchain innovations for addressing pharmaceutical counterfeit in the global supply chain: a PLS–ANN approach. |
|---|---|
| Authors: | Abumalloh, Rabab Ali1 (AUTHOR), Nilashi, Mehrbakhsh2 (AUTHOR) mehrbakhsh@ucsiuniversity.edu.my, Binti Tapsir, Siti Hamisah3 (AUTHOR), Shyu, Wen-Hwa4 (AUTHOR), Wei Han, Garry Tan2,5,6 (AUTHOR), Boon, Ooi Keng7,8,9 (AUTHOR) ooikengboon@gmail.com |
| Source: | International Journal of Production Research. Apr2026, Vol. 64 Issue 7, p2636-2660. 25p. |
| Subjects: | Blockchains, Drug counterfeiting, Innovation adoption, Pharmaceutical industry suppliers, Reliability in engineering, Warnings, Disclosure, Supply chains |
| Abstract: | There are obvious benefits of the adoption of blockchain innovation within the supply chain of pharmaceutical businesses, but there are significant obstacles hindering widespread adoption. This research aims to explore the relationships between transparency and three variables: reliability, responsiveness, and agility of the pharmaceutical supply chain. Besides, we examined the impacts of these three factors on the perceived value of blockchain. The influence of the perceived value on the blockchain adoption intention was also examined. Furthermore, this research examines the relationship between the intention to adopt blockchain technology and the perceived medicine safety. A new model of adoption is developed based on the Resource-Based View (RBV) and evaluated from the perspectives of stakeholders in Malaysian pharmaceutical and healthcare companies. The model is analyzed using two sequential approaches of Partial Least Squares-Structural Equation Modeling (PLS-SEM) and Artificial Neural Networks (ANNs). The findings revealed that supply chain transparency positively influences perceived reliability, responsiveness, and agility. These factors positively influence perceived value, which influences the adoption intention. Moreover, the results demonstrated that the adoption of blockchain can lead to safer medicines throughout the supply chain. [ABSTRACT FROM AUTHOR] |
| Copyright of International Journal of Production Research is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
